Teladoc Health reported a 2% year-over-year decrease in revenue to $642.4 million for Q2 2024. The company experienced a net loss of $837.7 million, which includes a goodwill impairment charge of $790.0 million. While the Integrated Care segment performed well, the BetterHelp segment faced continued headwinds.
Revenue decreased by 2% year-over-year to $642.4 million.
Net loss totaled $837.7 million, including a $790.0 million goodwill impairment charge.
Adjusted EBITDA increased by 24% year-over-year to $89.5 million.
Integrated Care revenue increased by 5% year-over-year, while BetterHelp revenue decreased by 9%.
Teladoc Health is withdrawing the financial outlook for the Full Year of 2024 for its Consolidated operations and its BetterHelp segment. For the third quarter of 2024, we expect Integrated Care Revenue growth percentage (year-over-year) 1% - 2% and Adjusted EBITDA margin 14.5% - 16.0%.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance